$SYM

KANE CHARLES sold $90K of SYM

KANE CHARLES sold 2,000 shares of Symbotic Inc. (SYM) at $44.90 on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KANE CHARLES
Published Jul 6, 2026, 11:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
medium confidence
Mentioned
$SYM
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

The disclosed open-market sale is pre-arranged under a Rule 10b5-1 plan, suggesting the transaction timing is not necessarily tied to new information.

02

Market read

Primarily a transparency datapoint; not a fundamental catalyst like earnings, guidance, contracts, or regulatory action.

03

What to watch

10b5-1 plans can be triggered regardless of company outlook; without a comparison to historical insider activity, the signal is weak.

Relevance 2/10Novelty 3/10Timing: New Form 4 filed July 6 (covers sale dated July 1).

Background

The article is a SEC Form 4 insider transaction disclosure for Symbotic Inc., reported by a director.

Company-level read

Ticker impact

$SYMNeutralMedium confidence
Context

Symbotic director Kane Charles filed a Form 4 open-market sale of 2,000 shares at $44.90 on July 1 under a 10b5-1 plan.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a disclosed insider transaction with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider activity without operational or guidance changes.

None indicated.

None indicated.

Counterpoint

If this sale is larger or more frequent than the director’s prior pattern, traders could treat it as a mild negative sentiment input despite the 10b5-1 label.

Key entities

  • Symbotic Inc.

    Company whose director insider sale is disclosed on Form 4.

  • Kane Charles

    Director who sold 2,000 shares at $44.90 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.

$OUSTMed

Robotics Stocks Rally as Unitree’s 8000X Oversubscribed IPO Draws Frenzied Demand: Ouster, Symbotic, and Teradyne in Focus

Robotics and physical AI stocks rose after China’s Unitree Robotics Shanghai IPO reportedly drew 8,000x retail oversubscription. In U.S. trading, Ouster gained 7% near $45, Symbotic rose 3% to about $41, and Teradyne added 3% to about $376. Ouster reported Q2 revenue of $54.63M (+55.9% YoY) and 17,000+ sensors; Symbotic has a ~$22.5B backlog. Analysts’ consensus targets cited $58 for OUST and $450 for TER.

$SYMHigh

Symbotic Inc. (SYM): Results of Operations and Financial Condition

Symbotic Inc. (SYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Symbotic Reports Third Quarter Fiscal Year 2026 Results Steve Pagliuca, Former Co-Chair of Bain Capital, Elected to Symbotic’s Board of Directors Wilmington, Massachusetts (August 5, 2026) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled